To explore whether SMAD2 or SMAD3 is responsible for the PNI of pancreatic cancer, we designed siRNA to knockdown SMAD2 and SAMD3 in PANC-1 cell line respectively. Here, SMAD3 is linked to pancreatic neoplasm.